Reporter March 26 2021
Mar. 26, 2021—A radiation therapy device for the treatment of a rare cancer has been designed, custom built and installed at Vanderbilt-Ingram Cancer Center at Maury Regional Spring Hill, offering patients from Alabama, Mississippi, Georgia and southern Tennessee more convenient care.
Mar. 26, 2021—Vanderbilt University Medical Center is becoming an official site of the U.S. Army Military-Civilian Trauma Team Training (AMCT3), formalizing a longstanding relationship between the two entities that is built on a history of collaborative success.
Mar. 25, 2021—Michael O’Connor, MD, assistant professor of Pediatrics at Monroe Carell Jr. Children’s Hospital at Vanderbilt, has been named medical director of the Primary Ciliary Dyskinesia (PCD) Foundation Registry, which he also helped develop.
Mar. 25, 2021—Chronic side effects among melanoma survivors after treatment with anti-PD-1 immunotherapies are more common than previously recognized, according to a study published March 25 in JAMA Oncology.
Mar. 25, 2021—Delvonte Mayberry was riding his motorcycle in his hometown of Clarksville, Tennessee, when a motorist pulled in front of him, sending him flipping over the vehicle. Mayberry was airlifted in critical condition to Vanderbilt University Medical Center via LifeFlight.
Mar. 25, 2021—Researchers from Vanderbilt’s Division of Nephrology and Hypertension have identified an under-studied characteristic that may have a protective effect on end-stage kidney disease (ESKD) risk among vulnerable populations.
Mar. 25, 2021—An FDA-approved medication enhances the function of T regulatory cells (Treg), a class of immune cells that restrains the immune response, Vanderbilt investigators have discovered.
Mar. 25, 2021—Ann Price, MD, who has served as associate dean of Vanderbilt Medical Alumni Affairs (VMAA) since 2008, will be stepping down from the position, effective July 1.
Mar. 25, 2021—Researchers from Vanderbilt University Medical Center are part of a multi-institutional study that aims to improve participation in lung cancer clinical trials among Black patients from Southern states.
Mar. 25, 2021—Longtime Vanderbilt University School of Medicine faculty member John Zic, MD, MMHC, professor of Dermatology, has been appointed vice chair for Clinical Affairs in the Department of Dermatology and executive medical director of the Dermatology Patient Care Center (PCC) at Vanderbilt University Medical Center.